The Clorox Company is a trusted name in consumer and professional products, with a significant presence in various segments. Despite facing challenges in the current market climate, its diversified portfolio across health, household, lifestyle, and international products provides a robust foundation for future growth.
The current fundamental rating of The Clorox Company reflects moderate performance with potential areas for improvement. Here's a detailed look:
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 1 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 3 | |
| Price to Book | 1 |
The historical data shows the evolution of scores over the recent past, representing a steady state.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-18 | 3 | 5 | 1 | 5 | 1 | 3 | 1 |
| Previous | 0 | 5 | 1 | 5 | 1 | 3 | 1 |
Analyst consensus offers guidance on potential stock movements with varying targets.
| High | Low | Median | Consensus |
|---|---|---|---|
| $152 | $94 | $121 | $121 |
Current analyst sentiment indicates a cautious stance towards CLX with predominant hold recommendations.
| Category | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 4 | |
| Hold | 20 | |
| Sell | 4 | |
| Strong Sell | 0 |
While The Clorox Company has a diverse and solid portfolio, the current market conditions pose challenges reflected in its moderate ratings. The overall analyst sentiment is cautious, indicating a predominant hold stance. Investors should weigh the company's historical performance against potential market reversals. CLX's steady market presence across consumer goods remains a cornerstone, though caution is advised given the aggregate analyst outlook.